Showing results (771-780 of 809) with videos related to

Sort By:
Pageof 81
Nature Communications|August 14, 2023
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trialLi Yuan, Guo-Dong Jia, Xiao-Fei Lv, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 10, 2022
Clinical implications and biological features of a novel postoperative recurrent HCC classification: A multi-centre studyLu-Nan Qi, Liang Ma, Fei-Xiang Wu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 6, 2009
Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinomaPei-Yu Huang, Hai-Qiang Mai, Dong-Hua Luo, et al.
Cancer Research and Treatment|September 15, 2017
Combination of Tumor Volume and Epstein-Barr Virus DNA Improved Prognostic Stratification of Stage II Nasopharyngeal Carcinoma in the Intensity Modulated Radiotherapy Era: A Large-Scale Cohort StudyQiu-Yan Chen, Shao-Yan Guo, Lin-Quan Tang, et al.
Journal of Nanobiotechnology|June 11, 2024
De novo design of a nanoregulator for the dynamic restoration of ovarian tissue in cryopreservation and transplantationMin Jiang, Guo-Hui Zhang, Yuan Yu, et al.
European Radiology|January 8, 2021
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control studyBei-Bei Xiao, Qiu-Yan Chen, Xue-Song Sun, et al.
BMC Medicine|March 17, 2023
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trialLin-Quan Tang, Xiao-Yun Li, Zhi-Ming Li, et al.
Cell Cycle (Georgetown, Tex.)|April 26, 2014
Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasisYing-Na Bao, Xue Cao, Dong-Hua Luo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2021
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CTBei-Bei Xiao, Da-Feng Lin, Xue-Song Sun, et al.
Oncoimmunology|May 8, 2015
Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinomaJiang Li, Qiu-Yan Chen, Jia He, et al.
Pageof 81